SOX9 Antikörper
-
- Target Alle SOX9 Antikörper anzeigen
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser SOX9 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunofluorescence (fixed cells) (IF/ICC)
- Aufreinigung
- Purified antibody
- Immunogen
- Purified recombinant fragment of human SOX9 expressed in E. Coli.
- Isotyp
- IgG1
- Top Product
- Discover our top product SOX9 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 0.5 % protein stabilizer.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles.
-
- Target
- SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))
- Andere Bezeichnung
- SOX9 (SOX9 Produkte)
- Hintergrund
- The protein encoded by this gene recognizes the sequence CCTTGAG along with other members of the HMG-box class DNA-binding proteins. It acts during chondrocyte differentiation and, with steroidogenic factor 1, regulates transcription of the anti-Muellerian hormone (AMH) gene. Deficiencies lead to the skeletal malformation syndrome campomelic dysplasia, frequently with sex reversal.
- Molekulargewicht
- 56 kDa
- Gen-ID
- 6662
- UniProt
- P48436
- Pathways
- EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development
-